Grace Therapeutics (GRCE) Tax Rate (2022 - 2026)
Grace Therapeutics' (GRCE) quarterly Tax Rate came in at 69.25% in Q1 2026, down 19724.0% year-over-year from N/an in Q1 2025, and down 74.01% quarter-over-quarter from 266.49% in Q1 2025.
Analysis
Grace Therapeutics (GRCE) Tax Rate (2022 - 2026) Analysis & Trends
Grace Therapeutics has disclosed Tax Rate across 5 years of filings, most recently posting 69.25% for Q1 2026.
- In Q1 2026, Tax Rate fell 19724.0% year-over-year to 69.25%; the TTM figure through Jun 2026 stood at 9.09% (down 1026.0% YoY), while the FY2026 annual figure was 20.99%, down 406.0% from the prior year.
- Tax Rate came in at 69.25% for Q1 2026 at Grace Therapeutics, down from 266.49% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 266.49% in Q1 2025 to a low of 3.05% in Q3 2022.
- Average Tax Rate over 5 years is 41.4%, with a median of 16.3% recorded in 2024.
- Year-over-year, Tax Rate surged 21369 bps in 2025 and plunged 19724 bps in 2026.
- Over 5 years, Tax Rate stood at 6.58% in 2022, then advanced by 22 bps to 8.0% in 2023, then soared by 59 bps to 12.71% in 2024, then surged by 1997 bps to 266.49% in 2025, then tumbled by 74 bps to 69.25% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 69.25% in Q1 2026, 266.49% in Q1 2025, and 12.71% in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 10.65% |
| 10 | Grace Therapeutics | 36.79 Mn | 36.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 69.25% |
| Mar 31, 2025 | 266.49% |
| Dec 31, 2024 | 12.71% |
| Sep 30, 2024 | 19.89% |
| Jun 30, 2024 | 21.67% |
| Mar 31, 2024 | 52.80% |
| Dec 31, 2023 | 8.00% |
| Sep 30, 2023 | 11.99% |
| Jun 30, 2023 | 6.70% |
| Mar 31, 2023 | 34.51% |
| Dec 31, 2022 | 6.58% |
| Sep 30, 2022 | 3.05% |
| Jun 30, 2022 | 5.08% |
| Mar 31, 2022 | 60.94% |